Effect of low-dose gaseous ozone on pathogenic bacteria
Carregando...
Citações na Scopus
43
Tipo de produção
article
Data de publicação
2012
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Citação
BMC INFECTIOUS DISEASES, v.12, article ID 358, 6p, 2012
Resumo
Background: Treatment of chronically infected wounds is a challenge, and bacterial environmental contamination is a growing issue in infection control. Ozone may have a role in these situations. The objective of this study was to determine whether a low dose of gaseous ozone/oxygen mixture eliminates pathogenic bacteria cultivated in Petri dishes. Methods: A pilot study with 6 bacterial strains was made using different concentrations of ozone in an ozone-oxygen mixture to determine a minimally effective dose that completely eliminated bacterial growth. The small and apparently bactericidal gaseous dose of 20 mu g/mL ozone/oxygen (1: 99) mixture, applied for 5min under atmospheric pressure was selected. In the 2nd phase, eight bacterial strains with well characterized resistance patterns were evaluated in vitro using agar-blood in adapted Petri dishes (10(5) bacteria/dish). The cultures were divided into 3 groups: 1-ozone-oxygen gaseous mixture containing 20 mu g of O-3/mL for 5 min; 2- 100% oxygen for 5 min; 3- baseline: no gas was used. Results: The selected ozone dose was applied to the following eight strains: Escherichia coli, oxacillin-resistant Staphylococcus aureus, oxacillin-susceptible Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis, extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, carbapenem-resistant Acinetobacter baumannii, Acinetobacter baumannii susceptible only to carbapenems, and Pseudomonas aeruginosa susceptible to imipenem and meropenem. All isolates were completely inhibited by the ozone-oxygen mixture while growth occurred in the other 2 groups. Conclusion: A single topical application by nebulization of a low ozone dose completely inhibited the growth of all potentially pathogenic bacterial strains with known resistance to antimicrobial agents.
Palavras-chave
Ozone, Resistant bacteria, in vitro study
Referências
- Aditya KG, 2012, J DERMATOLO IN PRESS
- Andersen BM, 2006, J HOSP INFECT, V62, P149, DOI 10.1016/j.jhin.2005.07.020
- Atiyeh BS, 2009, INT WOUND J, V6, P420, DOI 10.1111/j.1742-481X.2009.00639.x
- Aydogan A, 2006, J AIR WASTE MANAGE, V56, P179
- Bialoszewski Dariusz, 2003, Ortop Traumatol Rehabil, V5, P652
- Bikowski J, 1999, J EMERG MED, V17, P197, DOI 10.1016/S0736-4679(98)00150-4
- Bocci V, 2006, TOXICOL APPL PHARM, V216, P493, DOI 10.1016/j.taap.2006.06.009
- Boyce JM, 2009, INFECT CONT HOSP EP, V30, P515, DOI 10.1086/598999
- Boyce JM, 2007, J HOSP INFECT, V65, P50, DOI 10.1016/S0195-6701(07)60015-2
- BROADWAT.WT, 1973, APPL MICROBIOL, V26, P391
- Byrns G, 2011, J OCCUP ENVIRON HYG, V8, P104, DOI 10.1080/15459624.2011.547453
- Castillo A, 2008, QUINTESSENCE INT, V39, P827
- Davies A, 2011, J HOSP INFECT, V77, P199, DOI 10.1016/j.jhin.2010.08.012
- Dmitrieva N A, 2009, Stomatologiia (Mosk), V88, P14
- Fan L, 2007, J APPL MICROBIOL, V103, P2657, DOI 10.1111/j.1365-2672.2007.03522.x
- GURLEY B, 1985, Journal of Parenteral Science and Technology, V39, P256
- Johansson E, 2009, J DENT, V37, P449, DOI 10.1016/j.jdent.2009.02.004
- Kim HS, 2009, J KOREAN MED SCI, V24, P368, DOI 10.3346/jkms.2009.24.3.368
- Kowalski WJ, 2003, AIHA J, V64, P222, DOI 10.1080/15428110308984811
- Lipsky BA, 2009, CLIN INFECT DIS, V49, P1541, DOI 10.1086/644732
- Lochman P, 2010, SURG INFECT, V11, P29, DOI 10.1089/sur.2008.093
- Martinez-Sanchez G, 2005, EUR J PHARMACOL, V523, P151, DOI 10.1016/j.ejphar.2005.08.020
- MEHLMAN MA, 1987, ENVIRON RES, V42, P36, DOI 10.1016/S0013-9351(87)80005-1
- Moat J, 2009, CAN J MICROBIOL, V55, P928, DOI [10.1139/w09-046, 10.1139/W09-046]
- Moore G, 2000, J FOOD PROTECT, V63, P1100
- Pereira MMS, 2005, REV COL BRAS CIR, V32, P1
- Reimer K, 1997, DERMATOLOGY, V195, P93
- SCOTT D. B. McNAIR, 1963, JOUR BACTERIOL, V85, P567
- Steinhart H, 1999, EUR ARCH OTO-RHINO-L, V256, P153, DOI 10.1007/s004050050130
- Valacchi G, 2005, BRIT J DERMATOL, V153, P1096, DOI 10.1111/j.1365-2133.2005.06936.x
- Wainstein Julio, 2011, Diabetes Technol Ther, V13, P1255, DOI 10.1089/dia.2011.0018